SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011659
Filing Date
2021-08-13
Accepted
2021-08-13 15:43:14
Documents
70
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q krbp-20210630x10q.htm   iXBRL 10-Q 1686631
2 EX-31.1 krbp-20210630xex31d1.htm EX-31.1 22985
3 EX-31.2 krbp-20210630xex31d2.htm EX-31.2 19443
4 EX-32.1 krbp-20210630xex32d1.htm EX-32.1 7614
5 EX-32.2 krbp-20210630xex32d2.htm EX-32.2 7598
  Complete submission text file 0001558370-21-011659.txt   7202486

Data Files

Seq Description Document Type Size
6 EX-101.SCH krbp-20210630.xsd EX-101.SCH 47180
7 EX-101.CAL krbp-20210630_cal.xml EX-101.CAL 34154
8 EX-101.DEF krbp-20210630_def.xml EX-101.DEF 247758
9 EX-101.LAB krbp-20210630_lab.xml EX-101.LAB 456996
10 EX-101.PRE krbp-20210630_pre.xml EX-101.PRE 397306
11 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20210630x10q_htm.xml XML 1273766
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39619 | Film No.: 211171870
SIC: 2836 Biological Products, (No Diagnostic Substances)